Description
An antimalarial compound; increases mean survival time and abolishes malarial infection in mice at doses of 10 and 40 mg/kg, respectively; inhibits hemozoin formation, leading to an increase in free heme in purified trophozoites; A2A receptor antagonist; 5-HT2A and 5-HT2C agonist; has various effects on calcium homeostasis; has effects in mice typically associated with anxiolytic and antidepressant-like behavior
Formal name: rel-αS-(2R)-2-piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol, monohydrochloride
Synonyms: NSC 157387|Ro 21-5998/001
Molecular weight: 414.8
CAS: 51773-92-3
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Antiparasitics|Antiprotozoals||Product Type|Biochemicals|Receptor Pharmacology|Agonists||Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Parasitic Diseases|Malaria||Research Area|Neuroscience|Behavioral Neuroscience|Anxiety||Research Area|Neuroscience|Behavioral Neuroscience|Depression